Merouane Ounadjela

Iconic.

**A grand unified theory on what will happen in biotech in the next 10-20 years** the two major forces reshaping industrial biotech in the next decade are: 1. China 2. AI - and they're critically linked how? China's low R&D cost basis democratizes execution by providing…

Yeah, this is really well said and I agree. Western audiences have mostly scoffed at target/MOA discovery engines because there’s virtually no value capture for ideas. But like you’re saying, the medium to test these ideas definitively—chemical matter—is rapidly becoming a…

It’s wild to think that Sanger sequencing, which famously decoded the first 5,000-base genome of bacteriophage φX174, was invented almost half a century ago. The space has exploded with 10 companies and 37 instruments. If you factor in the different flow cell types and…

Excited to see progress in zero shot antibody design and its long term potential in shifting spend from exploration to validation Congrats Chai team!

To replace animal testing with AI, we need MASSIVE human datasets. Today, we're thrilled to share Axiom's new data exploration tool, providing the ability to visually explore the world's largest primary human liver toxicity dataset. Built with Axiom's proprietary wetlab…

Wonder if it’s time to start considering whether the old adage of “short the launch” should be put to bed. seems like the ability for SMID biopharma to commercialize is becoming sophisticated enough to stick around as long-term businesses… $BBIO $MDGL $VRNA

Announcing Axiom: Eliminating drug toxicity, without using animals! Alex Beatson and I founded Axiom a little over over a year ago with the mission of eliminating drug toxicity by replacing traditional experiments, such as animal testing, with AI models. We are excited to…